Howard L Kaufman

20PUBLICATIONS
41CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Gene and molecular therapyTumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (20)

|Sep 24, 2026
Long-Term Efficacy and Allograft Loss after Immune Checkpoint Inhibitor Therapy in Solid Organ Transplant Recipients with Advanced Cutaneous Squamous Cell Carcinoma.

|Sep 04, 2026
Beyond cold to hot: oncolytic virotherapy as the next cornerstone of immuno-oncology.

|Jul 20, 2026
Frontline immunotherapy with response-guided subsequent treatment (FIRST) in cutaneous squamous cell carcinoma: a Bayesian causal analysis of dose intensity, early benefit, and treatment de-escalation.

|May 13, 2026
Local immunotherapy for the treatment of cancer: scientific advances and clinical potential.

|Jan 14, 2026
Targeting Tumor-Draining Lymph Nodes to Improve the Therapeutic Potential of Oncolytic Viruses.

Howard L Kaufman

|Sep 16, 2025
Promoting the therapeutic potential of interleukin-7 (IL-7) by expression in viral vectors.

Myla Hudson, Robert H Newman, Checo J Rorie

Pageof 4

Frequent Collaborators

5 joint publications

Samuel D Rabkin

4 joint publications

Praveen K Bommareddy

3 joint publications

Dipongkor Saha

2 joint publications

Andrew Zloza